Delphia (Usa) Inc. Abbott Laboratories Transaction History

Delphia (Usa) Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $172,132 - $191,791	-1,708 Reduced 31.94%	3,639 $396,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $32,544 - $38,307	-336 Reduced 5.91%	5,347 $541,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $546,499 - $641,128	-5,749 Reduced 50.29%	5,683 $624,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $369,236 - $427,506	-3,816 Reduced 25.03%	11,432 $1.11 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $718,674 - $868,648	7,041 Added 85.79%	15,248 $1.66 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $196,684 - $239,844	1,725 Added 26.61%	8,207 $971,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $748,865 - $916,943	6,482 New	6,482 $912,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.